{"entity":{"id":"nuclear-medicine-and-biology","kind":"journal","name":"Nuclear Medicine and Biology","aka":["Nucl Med Biol","NMB"],"tldr":"A scientific journal for the chemistry side of radioactive drugs: how they are made, tested in cells and animals, and first tried in patients.","summary":"Nuclear Medicine and Biology began in 1973 as an Elsevier (then Pergamon Press) title and was rebranded in 1985 as Part B of the International Journal of Radiation Applications and Instrumentation before reverting to its current name; it is the official journal of the Society of Radiopharmaceutical Sciences. Its scope is radiopharmaceutical science across the full pipeline: automated and manual radiosynthesis, in vitro and ex vivo studies, in vivo biodistribution by dissection or imaging, radiopharmacology, radiopharmacy and translational clinical studies of new targeted radiotracers, with editorial guidance that the importance of the biological target should be the primary justification for publication, ahead of chemistry novelty alone.\n\nIt is a natural venue for first-in-human biodistribution and dosimetry papers on new PET/SPECT tracers and for methods papers on radiolabelling chemistry, generator systems and quality control — material that is often too preliminary or too chemistry-focused for the large clinical journals.\n\nElsevier's ScienceDirect Insights page for the journal states an impact factor of 3.0 and a CiteScore of 6.9; third-party trackers place the equivalent Clarivate JCR value in the range of roughly 2.6-3.0 depending on the release year, so the exact figure should be checked against the current JCR release before being quoted precisely.","asOf":"2026-09-22","links":[{"label":"Nuclear Medicine and Biology (ScienceDirect journal home)","url":"https://www.sciencedirect.com/journal/nuclear-medicine-and-biology"},{"label":"Society of Radiopharmaceutical Sciences: Journal page","url":"https://www.srsweb.org/journal"},{"label":"Nuclear Medicine and Biology — history note (60 years of Applied Radiation and Isotopes / Pergamon journals)","url":"https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=922075"}],"tags":["journal","radiochemistry","radiopharmacy"],"related":[],"indications":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"publisher":"Elsevier","url":"https://www.sciencedirect.com/journal/nuclear-medicine-and-biology","scope":"Radiopharmaceutical science: synthesis, in vitro/ex vivo evaluation, in vivo biodistribution, radiopharmacology, radiopharmacy and translational clinical studies of radiotracers.","access":"hybrid","founded":1973,"impactFactor":{"value":3,"year":2024,"source":"Elsevier ScienceDirect journal insights page for Nuclear Medicine and Biology; cross-checked against journalsimpactfactors.com (2024 JCR-based value 3.0)"},"matchNames":["Nuclear Medicine and Biology","Nucl Med Biol"],"society":"Society of Radiopharmaceutical Sciences"},"route":"/journals/nuclear-medicine-and-biology/","neighbours":{}}